描述

The global flow cytometry market is poised to grow by US$ 3,380.4 期间百万 2022-2028, 复合年增长率为 8.3% 在预测期内, 据数据和分析公司 StrategyHelix 称.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for flow cytometry. The global flow cytometry market is segmented on the basis of product, 技术, 应用, 最终用户, 和地区. 副产品, the global flow cytometry market has been segmented into kits and reagents, instruments, software and services, 其他的. The kits and reagents segment was the largest contributor to the global flow cytometry market in 2021. 以技术为基础, the global flow cytometry market is categorized into cell-based flow cytometry, bead-based flow cytometry. 据研究, the cell-based flow cytometry segment had the largest share in the global flow cytometry market. 根据应用, the global flow cytometry market has been segmented into cancer, drug discovery, stem cell therapy, organ transplantation, hematologic malignancy, 其他的. The cancer segment held the largest revenue share in 2021. 按最终用户, the global flow cytometry market has been segmented into hospitals and clinics, research institutes, pharmaceutical companies, 其他的. 全球范围, the hospitals and clinics segment made up the largest share of the flow cytometry market. 地理上, the global flow cytometry market is segmented into North America, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

The global flow cytometry market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Enzo Biochem Inc., Luminex Corporation, Miltenyi Biotec B.V. & 一氧化碳. 公斤, Sysmex Corporation, Thermo Fisher Scientific Inc. Competitive landscape gives a description of the competitive nature of the global flow cytometry market and a description of the leading companies. 确定了近年来塑造市场的关键金融交易.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the flow cytometry market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

产品: kits and reagents, instruments, software and services, 其他的
技术: cell-based flow cytometry, bead-based flow cytometry
应用: cancer, drug discovery, stem cell therapy, organ transplantation, hematologic malignancy, 其他的
最终用户: hospitals and clinics, research institutes, pharmaceutical companies, 其他的
地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美
考虑的年数: 本报告涵盖期间 2018 到 2028
提到的公司: Agilent Technologies Inc., Becton Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, Enzo Biochem Inc., Luminex Corporation, Miltenyi Biotec B.V. & 一氧化碳. 公斤, Sysmex Corporation, Thermo Fisher Scientific Inc.

利益相关者的主要好处

– Get a comprehensive picture of the global flow cytometry market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. Flow cytometry market overview
部分 3. 按产品划分的市场细分
– Kits and reagents
– 仪器
– Software and services
– 其他的
部分 4. 按技术划分的市场细分
– Cell-based flow cytometry
– Bead-based flow cytometry
部分 5. 按应用划分的市场细分
– Cancer
– Drug discovery
– Stem cell therapy
– Organ transplantation
– Hematologic malignancy
– 其他的
部分 6. 按最终用户划分的市场细分
– Hospitals and clinics
– Research institutes
– Pharmaceutical companies
– 其他的
部分 7. 按地区划分的市场细分
– 北美
– 欧洲
– 亚太
– 事物 (中东和非洲)
– 拉美
部分 8. 重点企业
– Agilent Technologies, 公司.
– Becton, Dickinson and Company
– BioMerieux SA
– Bio-Rad Laboratories Inc.
– Danaher Corporation
– Enzo Biochem Inc.
– Luminex Corporation
– Miltenyi Biotec B.V. & 一氧化碳. 公斤
– Sysmex Corporation
– Thermo Fisher Scientific Inc.
关于StrategyHelix
免责声明